|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/38 |
| (11) | Number of the document | 2709656 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12786365.2 |
| Date of filing the European patent application | 2012-05-15 | |
| (97) | Date of publication of the European application | 2014-03-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/037961 |
| Date | 2012-05-15 |
| (87) | Number | WO 2012/158701 |
| Date | 2012-11-22 |
| (30) | Number | Date | Country code |
| 201161487663 P | 2011-05-18 | US |
| (72) |
KILLEEN, Kevin, P., US
CARTEE, Robert, T., US
|
| (73) |
Matrivax, Inc.,
2nd Floor, Le Prince de Galles 3-5 Avenue des Citronniers, 98000 Monaco,
MC
|
| (54) | PROTEIN MATRIX VACCINE COMPOSITIONS INCLUDING POLYCATIONS |
| PROTEIN MATRIX VACCINE COMPOSITIONS INCLUDING POLYCATIONS |